share_log

丰原药业:安徽径桥律师事务所关于公司2022年限制性股票激励计划回购注销部分限制性股票的法律意见书

Fengyuan Pharmaceutical: Legal Opinion of Anhui Jingqiao Law Firm on the Company\'s 2022 Restricted Stock Incentive Plan to Repurchase and Cancel Some Restricted Shares

SZSI ·  Oct 10
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more